Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

China Medical’s SPR Diagnostic System Passes Test

publication date: Mar 25, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

China Medical Technologies (中国医疗技术公司) reported that its SPR-based Analysis System passed a milestone in its quest for SFDA approval. The system received a Quality Testing Certificate, indicating it met or surpassed all the safety and performance parameters required by the SFDA. The system has other tests ahead of it. China Medical continues to expect that approval for the SPR system and the HPV chip will be awarded before the end of 2009. China Medical paid $345 million to purchase the system in October 2008. More details...

Stock Symbol: (NSDQ: CMED)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at these events:
 
 
 
Hope to see you there!
 
ChinaBio® Events
ChinaBio Leadership Retreat 2014
Suzhou, China
October 23-24, 2014
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors